Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114943) titled 'A Prospective Clinical Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia Induced by Clofarabine in Pediatric Patients with Langerhans Cell Histiocytosis' on Dec. 19, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Second University Hospital, Sichuan University
Condition:
Langerhans cell histiocytosis
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: Intervention group:22;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300318
Publis...